39 results
8-K
EX-99.1
BIVI
BioVie Inc - Ordinary Shares
11 Mar 24
BioVie Announces Pipeline Update and Near-Term Clinical Priorities
5:00pm
for NE3107 as first-line monotherapy for recently diagnosed PD patients needing symptomatic therapy for the first time. The trial targets enrolling 100
424B5
ffx7isu
10 Aug 21
Prospectus supplement for primary offering
12:00am
424B5
bbln kex1guxyecwed
6 Aug 21
Prospectus supplement for primary offering
5:21pm
DEFM14C
fvf zu0mm
20 May 21
Information related to merger
4:47pm
PRER14C
22z4 nyxy3d41l
10 May 21
Preliminary revised information
4:44pm
PREM14C
kuj9j u33f5pz
4 May 21
Preliminary information related to merger
5:23pm
424B4
klfyo
18 Sep 20
Prospectus supplement with pricing info
7:13am